文献速递毛发、甲与色素性疾病

白癜风与抑郁:观察性研究的系统综述与荟萃分析

Vitiligo and depression: a systematic review and meta-analysis of observational studies.
PubMed 文献 · Br J Dermatol · 2017-07-23

该系统综述与荟萃分析纳入25项观察性研究、共2708例白癜风患者,评估白癜风患者中抑郁的患病率及风险。

要点

  • 临床应主动筛查白癜风患者抑郁症状并酌情转诊。

核心结论

  • 白癜风患者显著更可能罹患抑郁,临床抑郁或抑郁症状可较常见。

研究设计与样本

  • 系统综述与荟萃分析,检索MEDLINE、Embase和Cochrane Library,纳入横断面、病例对照或队列研究。
  • 共纳入25项研究、2708例白癜风患者。

主要发现

  • 研究间存在中高度异质性。

关键数值与推荐

  • 抑郁实际患病率可因筛查工具或地理区域不同而有所差异。

临床怎么用

  • 临床医生应主动评估白癜风患者的抑郁体征/症状,并酌情转诊以管理精神症状。

局限性

  • 研究间存在中高度异质性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Vitiligo is a common depigmenting disorder with profound psychosocial impacts. Previous observational studies have suggested a link between vitiligo and psychiatric morbidity, such as depression. However, variability in study design makes it difficult to quantify accurately the relationship between vitiligo and depression. We aimed to investigate the underlying prevalence and risk of depression among patients with vitiligo. A comprehensive search of MEDLINE, Embase and the Cochrane Library was conducted. Cross-sectional, case-control or cohort studies that assessed the prevalence of depression among patients with vitiligo or the relationship between vitiligo and depression were included. DerSimonian and Laird random-effects models were utilized to calculate the pooled prevalence and relative risks. Publication bias was evaluated by funnel plots and Egger's tests. Twenty-five studies with 2708 cases of vitiligo were included. Based on diagnostic codes, the pooled prevalence of depression among patients with vitiligo was 0·253 [95% confidence interval (CI) 0·16-0·34; P < 0·001)]. Using self-reported questionnaires, the pooled prevalence of depressive symptoms was 0·336 (95% CI 0·25-0·42; P < 0·001). The pooled odds ratio of depression among patients with vitiligo was 5·05 vs. controls (95% CI 2·21-11·51; P < 0·001). Moderate-to-high heterogeneity was observed between the studies. Patients with vitiligo were significantly more likely to suffer from depression. Clinical depression or depressive symptoms can be prevalent, with the actual prevalence differing depending on screening instruments or, possibly, geographical regions. Clinicians should actively evaluate patients with vitiligo for signs/symptoms of depression and provide appropriate referrals to manage their psychiatric symptoms accordingly.

来源:Br J Dermatol,查看原文。版权归原作者所有。

引用

  1. Lai YC, Yew YW, Kennedy C, et al. Vitiligo and depression: a systematic review and meta-analysis of observational studies. Br J Dermatol. 2017. PMID: 27878819. doi:10.1111/bjd.15199

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。